======= RXFP2 ======= == Gene Information == * **Official Symbol**: RXFP2 * **Official Name**: relaxin family peptide receptor 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=122042|122042]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WXD0|Q8WXD0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RXFP2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RXFP2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606655|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the GPCR (G protein-coupled, 7-transmembrane receptor) family. Mutations in this gene are associated with cryptorchidism. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]. * **UniProt Summary**: Receptor for relaxin. The activity of this receptor is mediated by G proteins leading to stimulation of adenylate cyclase and an increase of cAMP. May also be a receptor for Leydig insulin-like peptide (INSL3). |7tm 1| |Ldl recept a| |LRR 4| |protein-hormone receptor activity| |oocyte maturation| |positive regulation of cAMP-mediated signaling| |oocyte development| |activation of adenylate cyclase activity| |G protein-coupled peptide receptor activity| |peptide hormone binding| |oocyte differentiation| |regulation of cAMP-mediated signaling| |oogenesis| |adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway| |adenylate cyclase-activating G protein-coupled receptor signaling pathway| |female gamete generation| |male gonad development| |development of primary male sexual characteristics| |anatomical structure maturation| |cAMP-mediated signaling| |male sex differentiation| |cell maturation| |hormone-mediated signaling pathway| |cyclic-nucleotide-mediated signaling| |adenylate cyclase-modulating G protein-coupled receptor signaling pathway| |gonad development| |development of primary sexual characteristics| |developmental maturation| |G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger| |germ cell development| |sex differentiation| |second-messenger-mediated signaling| |cellular process involved in reproduction in multicellular organism| |reproductive structure development| |reproductive system development| |cellular response to hormone stimulus| |developmental process involved in reproduction| |negative regulation of cell population proliferation| |gamete generation| |multicellular organismal reproductive process| |sexual reproduction| |multicellular organism reproduction| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |response to hormone| |multi-organism reproductive process| |negative regulation of cell death| |positive regulation of intracellular signal transduction| |cellular response to endogenous stimulus| |G protein-coupled receptor signaling pathway| |integral component of plasma membrane| |reproductive process| |reproduction| |response to endogenous stimulus| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of cell population proliferation| |cell development| |positive regulation of signal transduction| |regulation of cell death| |intracellular signal transduction| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-2.59| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.09| |[[:results:exp273|Cisplatin 0.35μM R06 exp273]]|-1.93| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-1.86| |[[:results:exp326|CCT251545 20μM R07 exp326]]|-1.84| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|-1.84| |[[:results:exp532|TIC10 10μM R08 exp532]]|-1.82| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|-1.79| |[[:results:exp536|Vitamin-D3 40μM R08 exp536]]|-1.76| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|-1.72| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.72| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|1.77| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|1.82| |[[:results:exp375|Lenalidomide 20μM R07 exp375]]|1.86| |[[:results:exp151|SGC0946 7μM R03 exp151]]|2.18| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|2.19| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|2.23| |[[:results:exp212|Phenformin 20μM R05 exp212]]|2.25| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|2.31| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|2.46| |[[:results:exp225|Celastrol 0.12μM R05 exp225]]|2.6| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9512 * **Expression level (log2 read counts)**: -6.6 {{:chemogenomics:nalm6 dist.png?nolink |}}